This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Bacterial Infections  • HIV/AIDS  • Viral Infections  • Liver/ Biliary Tract/ Pancreatic Diseases  • Hematology, Other  • Immunology, Other  • Alert me on articles by topic

Jill Koshiol, PhD; Gloria Gridley, MS; Eric A. Engels, MD, MPH; Mary L. McMaster, MD; Ola Landgren, MD, PhD

Arch Intern Med. 2008;168(17):1903-1909.

Background  Certain autoimmune and infectious conditions are associated with increased risks of subtypes of non-Hodgkin lymphoma. A few previous studies suggest that chronic inflammation may particularly elevate risk of the distinct non-Hodgkin lymphoma subtype Waldenström macroglobulinemia (WM).

Methods  We assessed WM risk in relation to a variety of chronic immune stimulatory conditions in 4 million US veterans. We identified 361 patients with WM with up to 27 years of follow-up. Using time-dependent Poisson regression, we estimated rate ratios (RRs) and 95% confidence intervals (CIs) for WM risk in relation to history of autoimmune diseases that typically have autoantibodies (with systemic or organ involvement) or do not have autoantibodies, infections, and allergies. All the models were adjusted for attained age, calendar year, race, number of hospital visits, and latency between study entry and exit.

Results  The age-standardized incidence of WM was 0.34 per 100 000 person-years. Risk of WM was elevated in individuals with any previous autoimmune condition (RR, 2.23; 95% CI, 1.68-2.97), autoantibodies with systemic involvement (2.50; 1.55-4.02), or autoantibodies with organ involvement (2.30; 1.57-3.37). Risks of WM were also increased with hepatitis (RR, 3.39; 95% CI, 1.38-8.30), human immunodeficiency virus (12.05; 2.83-51.46), and rickettsiosis (3.35; 1.38-8.14).

Conclusions  In the largest investigation of WM risk factors to date, we found a 2- to 3-fold elevated risk of WM in persons with a personal history of autoimmune diseases with autoantibodies and notably elevated risks associated with hepatitis, human immunodeficiency virus, and rickettsiosis. These findings provide novel insights into the still unknown etiology of WM.

Author Affiliations: Cancer Prevention Fellowship Program, Office of Preventive Oncology (Dr Koshiol), and Division of Cancer Epidemiology and Genetics (Drs Koshiol, Engels, McMaster, and Landgren and Ms Gridley), National Cancer Institute, Bethesda, Maryland.

RELATED ARTICLE

In This Issue of Archives of Internal Medicine
Arch Intern Med. 2008;168(17):1842.
FULL TEXT